[Correspondence] Optimal imaging before local therapy of colorectal liver metastases

We read with interest, Burak Görgec and colleagues’ study,1 in which they report a change in the local treatment plan in patients with colorectal liver metastases based on liver contrast-enhanced MRI in 92 (31%) of 298 patients, with respect to the findings based on contrast-enhanced CT. Changes were made for 40 (13%) patients requiring more extensive local therapy, 11 (4%) patients requiring less extensive local therapy, and 34 (11%) patients in whom the indication for curative-intent local therapy was revoked, including 26 (9%) patients with too extensive disease, and eight (3%) patients with benign lesions on liver contrast-enhanced MRI.